.

ISSN 2063-5346
For urgent queries please contact : +918130348310

In Silico Study of Antimalarial Agents & Their Derivatives Against SARS-Cov-2 & Rheumatoid Arthritis: The New Face of Innovation

Main Article Content

H.K.S Sundeep Kumar1 , Priyadarshini Mishra1 , Mitali Sahoo 2 ,Suman Acharyya3 , Pratap Kumar Patra4 , Sujit Kumar Sahu1 , & Mrityunjay Banerjee1*
» doi: 10.31838/ecb/2023.12.4.291

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused COVID-19 pandemic has spread globally. On the other hand, Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically results in warm, swollen, and painful joints.

Article Details